Lentiviral-transduced HSC lead to long-term correction of beta-thalassemia by in vivo selection or erythroid progenitors.

A Miccio, R Cesari, C Rossi, F Tiboni, F Sanvito, M Ponzoni, S Routledge, M Antoniou, G Ferrari

Research output: Contribution to journal › Poster abstract

Original language	English
Article number	250
Pages (from-to)	S96 - S96
Journal	Molecular Therapy
Volume	15
Publication status	Published - 2007
Event	American Society of Gene Therapy (ASGT) 10th Annual Meeting - Seattle, WA, United States Duration: 30 May 2007 → 3 Jun 2007

Cite this

@article{9758bde1fe8f48c0a92d56bcf03c52de,

title = "Lentiviral-transduced HSC lead to long-term correction of beta-thalassemia by in vivo selection or erythroid progenitors.",

author = "A Miccio and R Cesari and C Rossi and F Tiboni and F Sanvito and M Ponzoni and S Routledge and M Antoniou and G Ferrari",

year = "2007",

language = "English",

volume = "15",

pages = "S96 -- S96",

journal = "Molecular Therapy",

issn = "1525-0024",

publisher = "Nature Publishing Group",

note = "American Society of Gene Therapy (ASGT) 10th Annual Meeting ; Conference date: 30-05-2007 Through 03-06-2007",

}

TY - JOUR

T1 - Lentiviral-transduced HSC lead to long-term correction of beta-thalassemia by in vivo selection or erythroid progenitors.

AU - Miccio, A

AU - Cesari, R

AU - Rossi, C

AU - Tiboni, F

AU - Sanvito, F

AU - Ponzoni, M

AU - Routledge, S

AU - Antoniou, M

AU - Ferrari, G

PY - 2007

Y1 - 2007

M3 - Poster abstract

SN - 1525-0024

VL - 15

SP - S96 - S96

JO - Molecular Therapy

JF - Molecular Therapy

M1 - 250

T2 - American Society of Gene Therapy (ASGT) 10th Annual Meeting

Y2 - 30 May 2007 through 3 June 2007

ER -